Diabetes and Neuro Products Ignite Medtronic's Q1 Earnings Rally

Medtronic TodayMDTMedtronic$87.86 +0.32 (+0.37%) 52-Week Range$68.84▼$89.24Dividend Yield3.19%P/E Ratio31.95Price Target$91.50Add to WatchlistShares of medical device manufacturer Medtronic PLC NYSE: MDT are down about 35% from their highs of roughly three years ago, but promising results from the company's first quarter of fiscal 2025, which ended July 26, could help to drive renewed upward momentum. Specifically, Medtronic's diabetes and neuromodulation products may be poised for breakout growth, and the ...